213.35
-3.95
(-1.82%)
At close: 5:32:18 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 7 | 18 | 18 |
Avg. Estimate | 17.6B | 14.63B | 62.83B | 65.68B |
Low Estimate | 17.4B | 14.39B | 62.74B | 64.39B |
High Estimate | 17.66B | 14.98B | 62.93B | 67.22B |
Year Ago Sales | 17.38B | 14.46B | 61.86B | 62.83B |
Sales Growth (year/est) | 1.27% | 1.18% | 1.57% | 4.54% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
IBM.VI | -- | -- | -- | -- |
S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
Maintains | UBS: Sell to Sell | 1/14/2025 |
Maintains | Bernstein: Market Perform to Market Perform | 1/3/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/16/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 10/24/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 10/24/2024 |
Maintains | BMO Capital: Market Perform to Market Perform | 10/24/2024 |